tiprankstipranks

Top UK Pharma & Biotech Shares

Compare UK pharmaceutical companies and biotech shares. See a comparison of key indicators, including pharma stock price targets and analyst recommendations.
Compare up to 10 stocks or ETFs

Comparison Results

Name
Price
Price Change
Volume
Market Cap
Analyst Price Target
Analyst Consensus
Smart Score
Article
Follow
GB:AZN
AstraZeneca
12276.00p
156p
(1.29%)
251.14K£187.86B
13 Buy
4 Hold
1 Sell
Moderate Buy
GB:GSK
GlaxoSmithKline
1772.50p
14.5p
(0.82%)
864.87K£71.81B
8 Buy
4 Hold
2 Sell
Moderate Buy
GB:HIK
Hikma Pharmaceuticals
1971.00p
6p
(0.31%)
30.93K£4.34B
2 Buy
5 Hold
0 Sell
Moderate Buy
GB:HCM
HUTCHMED (China) Limited
313.00p
5p
(1.62%)
151.04K£2.76B
2 Buy
0 Hold
0 Sell
Moderate Buy
GB:DPH
DPH

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GB:AZN
AstraZeneca
12,264.00
609.30
5.23%
GB:GSK
GlaxoSmithKline
1,773.50
383.73
27.61%
GB:HIK
Hikma Pharmaceuticals
1,973.00
165.64
9.16%
GB:HCM
HUTCHMED (China) Limited
313.00
85.25
37.43%
GB:DPH
3,866.00
200.00
5.46%
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Pharma & Biotech Stocks Latest News

Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Pharma & Biotech Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
GlaxoSmithKline
Buy
Reiterated
Hikma Pharmaceuticals
Hold
Reiterated
HUTCHMED (China) Limited
Buy
Initiated
GlaxoSmithKline
Hold
Reiterated
GlaxoSmithKline
Buy
Reiterated
GlaxoSmithKline
Hold
Reiterated
Hikma Pharmaceuticals
Buy
Reiterated

Most Recent Earnings of Pharma & Biotech Stocks

Name
Report Date
Time Of Day
Period Ending
Forecast / EPS
Last Year's EPS
AstraZeneca
Apr 25, 2024
Mar 01, 2024
153.02 / 164.95
215
GlaxoSmithKline
May 01, 2024
Mar 01, 2024
36.70 / 43.10
38.8
Hikma Pharmaceuticals
Feb 22, 2024
Dec 01, 2023
- / 21.40
127.9
HUTCHMED (China) Limited
Feb 28, 2024
Dec 01, 2023
-17.30 / -11.21
1.946
DPH
- / -

Pharma & Biotech Stocks - FAQ

Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
    Are Pharma & Biotech stocks overpriced?
    AstraZeneca's stock price is currently 12,276.00p, and its average 12-month price target is 11,955.67p.
      GlaxoSmithKline's stock price is currently 1,772.50p, and its average 12-month price target is 1,924.10p.
        Hikma Pharmaceuticals's stock price is currently 1,971.00p, and its average 12-month price target is 2,210.71p.
          HUTCHMED (China) Limited's stock price is currently 313.00p, and its average 12-month price target is 358.48p.
            's stock price is currently N/A, and its average 12-month price target is N/A.
              Which Pharma & Biotech stocks pay dividends?
              AstraZeneca does not currently pay dividends.
                GlaxoSmithKline currently pays a dividend of 15.00p which represents an annual dividend yield of 3.35%. GlaxoSmithKline's next Ex-dividend date is May 16, 2024 and its next payout date is July 11, 2024.
                  Hikma Pharmaceuticals does not currently pay dividends.
                    HUTCHMED (China) Limited does not currently pay dividends.
                      does not currently pay dividends.

                        Latest News​

                        Joey FrenetteMeta’s Heavy Investments in AI, Metaverse Could Payoff Big Time
                        Paul HoffmanAI Loves AC: A Chill Way for Cautious Investors to Capture AI Growth
                        Jordan SauerCitigroup Stock (NYSE:C): Can It Become Like JPMorgan Chase?
                        Marty ShtrubelApple Stock: ‘An AI Play in Waiting,’ Says Daniel Ives
                        Marty ShtrubelTime to Load Up on Rivian Stock? Wall Street Analysts Weigh In
                        Michael ByrnePhilip Morris (NYSE:PM): More Than Just a Defensive Dividend Stock
                        Marty ShtrubelCan Nvidia Stock Reach Record High of $1,100? Here’s What Goldman Sachs Expects
                        Vince CondarcuriHOOD Earnings: Robinhood Surges amid Solid Q1 Results
                        Joey FrenetteApple Stock (NASDAQ:AAPL): 110 Billion Reasons to Buy after Buffett Sold
                        Vince CondarcuriARM Earnings: Shares Plunge despite Stellar Q4 Results
                        Vince CondarcuriABNB Earnings: Airbnb Sinks despite Big EPS Beat
                        Steve AndersonInvestors Hold Breath as Warner Bros (NASDAQ:WBD) Considers Cost-Cutting
                        Amit SinghStock Market News Today, 05/08/24 – Indices Finish Mixed; Mortgage Rate Falls
                        Steve AndersonNew Analyst Commentary Sends Boston Beer (NYSE:SAM) Bubbling Up
                        Steve AndersonNew Battery Deal Can’t Save Nio (NYSE:NIO) from Plunging

                        Pharma & Biotech Stock Events

                        Stock
                        Type
                        Date
                        GlaxoSmithKline
                        Ex-Dividend DateMay 16, 2024
                        AstraZeneca
                        Earnings ReleaseJul 25, 2024
                        GlaxoSmithKline
                        Earnings ReleaseJul 31, 2024
                        HUTCHMED (China) Limited
                        Earnings ReleaseJul 31, 2024
                        Hikma Pharmaceuticals
                        Earnings ReleaseAug 08, 2024

                        Popular Stocks

                        Company
                        Price & Change
                        Follow
                        Nvidia
                        Apple
                        Microsoft